Vivanza Biosciences Ltd

📊 Vivanza Biosciences: No Fundraising or Statement Deviation Required

• No deviation or variation statement required under SEBI Regulation 32

• No funds raised through public issue, rights issue, preferential issue, or QIP

• Confirmation submitted to BSE Limited on April 14, 2026

• Signed by Chaitra Arora, Company Secretary & Compliance Officer